Lv5
1120 积分 2020-04-04 加入
Drawing a line in the sand: impact of analytical choices on anti-drug antibody cut-points and testing outcomes
23小时前
已完结
Calculating Receptor Occupancy using TMDD Models – What has to be Considered?
23小时前
已完结
Drawing a line in the sand: impact of analytical choices on anti-drug antibody cut-points and testing outcomes
9天前
已完结
Pharmaceutical drug monitoring: the role of oral fluid sampling
1个月前
已关闭
Advances in the use of DNA aptamers for bioanalysis of antibody-based therapeutics
1个月前
已关闭
Preclinical pharmacokinetics of novel MYDGF for human PK and dose prediction
1个月前
已关闭
Validation approach of an LC-MS/MS assay for ADA detection, applied to a Von Willebrand factor-targeted biotherapeutic
1个月前
已完结
An update on the European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: biomarker and anti-drug-antibody assays
1个月前
已完结
Bioanalytical challenges and solutions for immunogenicity evaluation of bispecific antibody therapeutics
1个月前
已完结
AI-assisted integrative framework combining microarray data analysis and cerebrospinal fluid pharmacology for revealing molecular mechanism in Alzheimer’s disease: A case study of Psoraleae Fructus
1个月前
已完结
皖公网安备34019202002308
